News on research and diagnostics for metabolic disorders and metabolic diseases.
The scientists developed a metabolomic panel capable of predicting BMI and identifying subsets of at-risk patients with apparently healthy BMIs.
The National Institutes of Health Commercial Accelerator Program helps small healthcare and life science companies bring their products to market.
Researchers found that when combined into a risk score, heart disease loci identified in the general population were also associated with heart disease in type 2 diabetes.
The companies will combine their respective technologies to create a platform for discovering and developing drugs for certain genetic diseases.
Using samples from obese women with hepatic steatosis, investigators uncovered ties between the condition, gut microbes, metabolites, and liver gene expression.
